Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A open label non- randomized Phase II trial. It is anticipated that approximately 46 patients
will be treated.
STUDY OBJECTIVES
Primary: Objective response rate
Secondary: Progression free survival, Overall survival and Safety of Tarceva